Top Markets
Coin of the day
Gujarat Themis Biosyn Ltd. Gujarat Themis Biosyn Ltd.

Gujarat Themis Biosyn Ltd.

GUJTHEM
Rangering i aksjer #13247
Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the... Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the creation of pharmaceuticals and medicinal chemicals. The firm also supplies bulk drugs via a job work model within India. Its product offerings include important compounds such as Rifamycin-S, an intermediate used in treatments for tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease. Another key product, Rifamycin-O, addresses ailments like traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Furthermore, they produce Lovastatin. Established in 1981, the company's operations are based out of Mumbai, India.
Aksjekurs
$4.66
Markedsverdi
$507.71M
Endring (1 dag)
2.94%
Endring (1 år)
8.43%
Land
IN
Handel Gujarat Themis Biosyn Ltd. (GUJTHEM)

Kategori

EPS for Gujarat Themis Biosyn Ltd. (GUJTHEM)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Gujarat Themis Biosyn Ltd. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Gujarat Themis Biosyn Ltd. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter